CD4 T cells are important for immunity to tuberculosis as a result of they produce cytokines, together with interferon-γ. Whether or not CD4 T cells act as “helper” cells to advertise optimum CD8 T cell responses throughout Mycobacterium tuberculosis is unknown.
Utilizing two unbiased fashions, we present that CD4 T cell assist enhances CD8 effector features and prevents CD8 T cell exhaustion. We show synergy between CD4 and CD8 T cells in selling the survival of contaminated mice.
Purified helped, however not helpless, CD8 T cells effectively prohibit intracellular bacterial progress in vitro. Thus, CD4 T cell assist performs a vital function in producing protecting CD8 T cell responses towards M. tuberculosis an infection in vitro and in vivo.
We infer vaccines that elicit each CD4 and CD8 T cells are extra seemingly to achieve success than vaccines that elicit solely CD4 or CD8 T cells.

Latent Tuberculosis An infection Screening and Remedy in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Launch Assay Cohort

In 2017, the Korean authorities launched an unprecedentedly large-scaled latent tuberculosis an infection (LTBI) screening venture which lined greater than one million people in congregate settings.
A complete of 1,047,689 contributors of supply inhabitants (n = 2,336,157) underwent LTBI testing from 2017 to 2018. The general LTBI check uptake price throughout this venture was 44.8%. Staff in daycare facilities (83.5%) and kindergartens (78.9%) confirmed excessive participation price.
A complete of 1,012,206 people with legitimate outcomes of interferon-gamma launch assay (IGRA) have been chosen to represent the IGRA cohort. Many of the enrolled contributors within the IGRA cohort have been of their working age.
Roughly, three-quarters of complete enrolled inhabitants have been feminine. Investigating the LTBI prevalence, phases of LTBI care cascade, pure historical past of LTBI, efficacy of LTBI remedy and cost-effectiveness of LTBI screening are possible inside this IGRA cohort.

Building of a eukaryotic expression system with secure and secretory expression of mycobacterium tuberculosis 38 kDa protein

The 38 kDa protein is a serious antigen of mycobacterium tuberculosis and has been broadly utilized in TB serodiagnosis, on account of its extremely sensitivity and specificity. Right here we try to ascertain a manufacturing platform of recombinant 38 kDa protein in mammalian cells and to guage the potential worth of 38 kDa protein in TB serodiagnosis.
The 38 kDa gene is synthesized and cloned right into a lentiviral expressing vector. Recombinant lentiviral vector LV-CMV-38 kDa-eGFP was packaged, titered, after which transduced into HEK 293 T cells. Recombinant cell traces have been chosen by limiting dilution.
Supernatants have been collected and purified by HisTrapTM HP column. Western blot confirmed a molecular weight of approximate 38 kDa in cell supernatants as anticipated. ELISA assay confirmed the immunological specificity of the obtained protein within the presence of MTB-infected human serum samples.
In all, we now have obtained a secure cell line with long-term and sturdy expression of secretory MTB 38 kDa protein, which can present a promising candidate antigen for the event of TB serological analysis.

Interplay of host sample recognition receptors (PRRs) with Mycobacterium tuberculosis and Ayurvedic administration of tuberculosis: a systemic strategy

Tuberculosis (TB) an infectious illness brought on by Mycobacterium tuberculosis (Mtb), infects the lungs’ alveolar surfaces by the aerosol droplets. At this stage, the illness development might have many penalties, decided primarily by the reactions of the human immune system.
Nonetheless one strategy shall be to extra actively combine the immune system; particularly the sample recognition receptor (PRR) methods of the host, which notices pathogen-associated molecular patterns (PAMPs) of Mtb. A number of varieties of PRRs are concerned within the detection of Mtb together with Toll-like receptors (TLRs), C-type lectin receptors (CLRs),
Dendritic cell (DC) -specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), Mannose receptor (MR) and NOD-like receptors (NLRs) associated to inflammasome activation.
On this examine, we focus to assessment the Mtb pathophysiology and interplay of host PPRs with Mtb in addition to hostile drug results of anti-tuberculosis medicine (ATDs) and systematic TB remedy by way of Ayurvedic drugs.

6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis progress by alteration of tryptophan biosynthesis

A significant constraint in decreasing tuberculosis epidemic is the emergence of strains immune to a number of of clinically permitted antibiotics, which emphasizes the necessity of novel medicine with novel targets.
Genetic knockout strains of Mycobacterium tuberculosis (Mtb) have established that tryptophan (Trp) biosynthesis is crucial for the bacterium to outlive in vivo and trigger illness in animal fashions.
An anthranilate-like compound, 6-FABA, was beforehand proven to synergize with the host immune response to Mtb an infection in vivo. Herein, we current a category of anthranilate-like compounds endowed with good antimycobacterial exercise and low cytotoxicity.
We present how changing the carboxylic moiety with a hydrazide led to a big enchancment in each exercise and cytotoxicity relative to the guardian compound 6-FABA. A number of new benzohydrazides (compounds 20-31, 33, 34, 36, 38 and 39) confirmed good actions towards Mtb (0.625 ≤ MIC≤6.25 μM) and demonstrated no detectable cytotoxicity towards Vero cell assay (CC50 ≥ 1360 μM).
The goal preliminary research confirmed the speculation that this new class of compounds inhibits Trp biosynthesis. Taken collectively, these findings point out that fluorophenylbenzohydrazides symbolize good candidates to be assessed for drug discovery.

Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and goal Pik1

The pathogen Mycobacterium tuberculosis (Mtb) evades the innate immune system by interfering with autophagy and phagosomal maturation in macrophages, and, in consequence, small molecule stimulation of autophagy represents a host-directed therapeutics (HDTs) strategy for remedy of tuberculosis (TB).
Right here we present the marine pure product clionamines activate autophagy and inhibit Mtb survival in macrophages. A yeast chemical-genetics strategy recognized Pik1 as goal protein of the clionamines. Biotinylated clionamine B pulled down Pik1 from yeast cell lysates and a clionamine analog inhibited phosphatidyl 4-phosphate (PI4P) manufacturing in yeast Golgi membranes.
Chemical-genetic profiles of clionamines and cationic amphiphilic medicine (CADs) are intently associated, linking the clionamine mode of motion to co-localization with PI4P in a vesicular compartment.

Brucella Abortus Antigen
NAT41599-500 0.5
EUR 1176.24
Description: Brucella abortus lysate, produced by fermentation.

Candida Albicans Antigen
NAT41601-100 0.1
EUR 391.66
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Candida Albicans Antigen
NAT41601-500 0.5
EUR 1176.24
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Canine Parvovirus Antigen
NAT41594-100 0.1
EUR 391.66
Description: Canine Parvovirus, produced in CRFK cells.

Canine Coronavirus Antigen
NAT41590-100 0.1
EUR 391.66
Description: Canine Coronavirus produced in A-72 cells.

Feline Calicivirus Antigen
NAT41595-100 0.1
EUR 391.66
Description: Feline Calicivirus produced in FC 3TG cells.

Helicobacter Pylori Antigen
NAT41603-100 0.1
EUR 391.66
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Helicobacter Pylori Antigen
NAT41603-500 0.5
EUR 1176.24
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Campylobacter Jejuni Antigen
NAT41600-100 0.1
EUR 391.66
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Campylobacter Jejuni Antigen
NAT41600-500 0.5
EUR 1176.24
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

mycobacterium tuberculosis Antigen 85A Recombinant Protein
PROTP9WQP3 10ug
EUR 265
Description: mycobacterium tuberculosis Antigen 85A Recombinant Protein expressed in Baculovirus with His-tag. Sequence domain: 44-338aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method).

Chlamydia Trachomatis Antigen
CT022-1000 1.0
EUR 378.9
Description: Chlamydia trachomatis antigens from clarified cell lysate.

Neisseria Gonorrhoeae Antigen
NG01-1000 1.0
EUR 378.9
Description: Homogenised lysate of pure bacteria.

Mycoplasma Pneumoniae Antigen
MP901-1000 1.0
EUR 1010.39
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Mycoplasma Pneumoniae Antigen
MP901-200 0.2
EUR 270.46
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Echovirus Antigen, Recombinant
REC31776-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Echovirus Antigen, Recombinant
REC31776-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Trichomonas Vaginalis Antigen
TV01-1000 1.0
EUR 421
Description: Washed & lysed suspension of whole protozoa

Echinococcus Granulosus Antigen
NAT41602-100 0.1
EUR 391.66
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Echinococcus Granulosus Antigen
NAT41602-500 0.5
EUR 1176.24
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Enterovirus Antigen, Recombinant
REC31772-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Enterovirus Antigen, Recombinant
REC31772-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Cytomegalovirus Purified Antigen
CMV-HP-100 0.1
EUR 318.94
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen
CMV-HP-1000 1.0
EUR 2096.06
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen
CMV-HP-500 0.5
EUR 1279.58
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Astrovirus Antigen (Type 1)
AS02-1000 1.0
EUR 1654.65
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Astrovirus Antigen (Type 1)
AS02-200 0.2
EUR 442.69
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Yersinia pestis V antigen
REC32028-100 0.1
EUR 491.53
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Yersinia pestis V antigen
REC32028-500 0.5
EUR 2421.37
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Canine Herpes Virus Antigen
NAT41592-100 0.1
EUR 391.66
Description: Canine Herpes virus, produced in MDCK cells.

Canine Adenovirus 1 Antigen
NAT41587-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 1, produced in A-72 cells.

Canine Adenovirus 2 Antigen
NAT41588-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 2, produced in A-72 cells.

Canine Distemper Virus Antigen
NAT41591-100 0.1
EUR 391.66
Description: Canine Distemper virus, produced in SL-29 cells.

Canine Parainfluenza Virus Antigen
NAT41593-100 0.1
EUR 391.66
Description: Canine Parainfluenza virus antigen, produced in MDCK cells.

Feline Panleukopenia Virus Antigen
NAT41597-100 0.1
EUR 391.66
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells.

Norovirus GII.4 VP1 Antigen
REC31620-100 0.1
EUR 302.36
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen
REC31620-1000 1.0
EUR 1830.71
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen
REC31620-500 0.5
EUR 1066.53
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Cytomegalovirus Cell Lysate Antigen
CMV-CL-100 0.1
EUR 223.26
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Cytomegalovirus Cell Lysate Antigen
CMV-CL-1000 1.0
EUR 1422.47
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Feline Viral Rhinotracheitis Antigen
NAT41598-100 0.1
EUR 391.66
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells.

Herpes Simplex Virus 1 Antigen
HS105-1000 1.0
EUR 1178.79
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 1 Antigen
HS105-200 0.2
EUR 294.7
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen
HS205-1000 1.0
EUR 1178.79
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen
HS205-200 0.2
EUR 294.7
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Ross River Virus Recombinant Antigen
REC31969-100 0.1
EUR 757.8
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Ross River Virus Recombinant Antigen
REC31969-500 0.5
EUR 2844.92
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Canine Adenovirus 1 and 2 Antigen
NAT41589-100 0.1
EUR 391.66
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells.

Hepatitis B Virus E Antigen (HBeAg)
REC31677-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Hepatitis B Virus E Antigen (HBeAg)
REC31677-500 0.5
EUR 1941.06
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Hepatitis B Virus Core Antigen (HBcAg)
REC31689-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis B Virus Core Antigen (HBcAg)
REC31689-500 0.5
EUR 1370.16
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis C Virus Core Antigen (HCcAg)
REC31693-100 0.1
EUR 484.79
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Hepatitis C Virus Core Antigen (HCcAg)
REC31693-500 0.5
EUR 1455.64
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Feline Infectious Peritonitis Virus Antigen
NAT41596-100 0.1
EUR 391.66
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells.

Herpes Simplex Virus 1 Lysate Antigen
HS104-1000 1.0
EUR 270.46
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate.

Herpes Simplex Virus 2 Lysate Antigen
HS204-1000 1.0
EUR 270.46
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate.

Legionella pneumophila antigen (native extract)
NAT41580-100 0.1
EUR 391.66
Description: Inactivated Legionella pneumophila antigen from culture.

Streptococcus Pneumoniae Antigen, Native Extract
NAT41604-100 0.1
EUR 391.66
Description: Inactivated Streptococcus pneumoniae antigen from culture.

Leptospira Biflexa Antigen (Strain Patoc 1)
NAT41582-100 0.1
EUR 391.66
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Leptospira Biflexa Antigen (Strain Patoc 1)
NAT41582-500 0.5
EUR 1176.24
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Antigen 85A, 43-338aa, Mycobacterium tuberculosis, His tag, Baculovirus
MBS204142-001mg 0.01mg
EUR 230

Antigen 85A, 43-338aa, Mycobacterium tuberculosis, His tag, Baculovirus
MBS204142-005mg 0.05mg
EUR 405

Antigen 85A, 43-338aa, Mycobacterium tuberculosis, His tag, Baculovirus
MBS204142-025mg 0.25mg
EUR 985

Antigen 85A, 43-338aa, Mycobacterium tuberculosis, His tag, Baculovirus
MBS204142-5x025mg 5x0.25mg
EUR 4180

Mouse Anti-Hepatitis B Surface Antigen Antibody (1834)
MAB12230-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834).

Mouse Anti-Hepatitis B Surface Antigen Antibody (1837)
MAB12231-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837)

Mouse Anti-Hepatitis B Surface Antigen Antibody (1838)
MAB12232-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892)
MAB12226-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893)
MAB12227-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894)
MAB12228-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894)

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein
20-abx262511
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 2 µg

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein
abx262511-10mg 10 mg
EUR 325

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein
abx262511-25mg 25 mg
EUR 6575

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein
abx262511-5mg 5 mg
EUR 225

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)
MAB12298-100 0.1
EUR 276.84
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)
MAB12298-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)
MAB12299-100 0.1
EUR 276.84
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)
MAB12299-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

Mycobacterium Tuberculosis major secretory protein Antigen 85A Recombinant
rAP-3658 Inquiry Ask for price

Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85A
MBS144787-0002mg 0.002mg
EUR 240

Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85A
MBS144787-001mg 0.01mg
EUR 310

Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85A
MBS144787-1mg 1mg
EUR 5345

Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85A
MBS144787-5x1mg 5x1mg
EUR 23725

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag
REC32027-100 0.1
EUR 491.53
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag
REC32027-500 0.5
EUR 2421.37
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Ag85A Mycobacterium Tuberculosis major secretory protein Antigen 85A Recombinant Protein
PROTP0A4V2 Regular: 10ug
EUR 380.4
Description: Recombinant Mycobacterium tuberculosis Ag85A (43-338 a.a) produced in Hi-5 cells is a single, glycosylated polypeptide chain having a molecular mass of 32.8kDa (305 a.a in total).;Antigen 85A is fused to a His tag at C-terminus and purified by conventional chromatographic techniques.

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A)
MBS6006525-02mL 0.2(mL
EUR 695

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A)
MBS6006525-5x02mL 5x0.2mL
EUR 2975

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (AP)
MBS6301005-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (AP)
MBS6301005-5x02mL 5x0.2mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (PE)
MBS6301015-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (PE)
MBS6301015-5x02mL 5x0.2mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (APC)
MBS6301006-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (APC)
MBS6301006-5x02mL 5x0.2mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (FITC)
MBS6301008-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (FITC)
MBS6301008-5x02mL 5x0.2mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (Biotin)
MBS6301007-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (Biotin)
MBS6301007-5x02mL 5x0.2mL
EUR 4250

HCV NS3 1359-1456aa antigen
00154-V-01mg 0,1 mg
EUR 321
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6

HCV NS3 1359-1456aa antigen
00154-V-1000ug 1000 ug
EUR 1539
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6

HLA Class 1 Antigen A25,A32
MBS602885-01mL 0.1mL
EUR 1290

HLA Class 1 Antigen A25,A32
MBS602885-5x01mL 5x0.1mL
EUR 5650

HLA Class 1 Antigen A23,A24
MBS602995-01mL 0.1mL
EUR 1380

HLA Class 1 Antigen A23,A24
MBS602995-5x01mL 5x0.1mL
EUR 6060

A549 HCP Control Antigen
F237 50 ul
EUR 308.4
Description: A549 HCP Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Cancer Antigen 242 Antigen
VAng-Cr3876-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration.

HLA Class 1 Antigen A11
MBS601315-01mL 0.1mL
EUR 1380

HLA Class 1 Antigen A11
MBS601315-5x01mL 5x0.1mL
EUR 6060

HLA Class 1 Antigen A29
MBS603635-01mL 0.1mL
EUR 1380

HLA Class 1 Antigen A29
MBS603635-5x01mL 5x0.1mL
EUR 6060

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 405)
MBS6301010-01mL 0.1mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 405)
MBS6301010-5x01mL 5x0.1mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 490)
MBS6301011-01mL 0.1mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 490)
MBS6301011-5x01mL 5x0.1mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 550)
MBS6301012-01mL 0.1mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 550)
MBS6301012-5x01mL 5x0.1mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 650)
MBS6301013-01mL 0.1mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 650)
MBS6301013-5x01mL 5x0.1mL
EUR 4250

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 750)
MBS6301014-01mL 0.1mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (MaxLight 750)
MBS6301014-5x01mL 5x0.1mL
EUR 4250

Antigen 85-A Antibody (HRP)
20-abx109227
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A Antibody (FITC)
20-abx107809
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A (fbpA) Antibody
abx110661-100l 100 µl
EUR 162.5

A549 HCP Antigen Concentrate
F233G 200 ul
EUR 540
Description: A549 HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur.

Antigen 85-A (Ag85A) Antibody
20-abx110661
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

HLA Class 1 Antigen A9,A25,A32
MBS603207-01mL 0.1mL
EUR 1380

HLA Class 1 Antigen A9,A25,A32
MBS603207-5x01mL 5x0.1mL
EUR 6060

HLA Class 1 Antigen A30,A31 (R0.92)
MBS602833-01mL 0.1mL
EUR 1290

HLA Class 1 Antigen A30,A31 (R0.92)
MBS602833-5x01mL 5x0.1mL
EUR 5650

Antigen 85-A Antibody (Biotin)
20-abx106397
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (Azide free) (HRP)
MBS6301009-02mL 0.2mL
EUR 980

GAGE13, NT (GAGE13, GAGE12A, G antigen 13, G antigen 12A) (Azide free) (HRP)
MBS6301009-5x02mL 5x0.2mL
EUR 4250

CEA Antigen (Antigen Grade)
GWB-378447 1 mg Ask for price

Cancer Antigen 50 Antigen
VAng-Cr3877-50kU 50 kU
EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

HLA Class 1 Antigen A23,A24 (IgM)
MBS602652-01mL 0.1mL
EUR 1380

HLA Class 1 Antigen A23,A24 (IgM)
MBS602652-5x01mL 5x0.1mL
EUR 6060

HLA Class 1 Antigen A34,B71,A26
MBS604281-01mL 0.1mL
EUR 1290

HLA Class 1 Antigen A34,B71,A26
MBS604281-5x01mL 5x0.1mL
EUR 5650

Cancer Antigen 72-4 Antigen
VAng-Cr3878-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Hepatitis B Core Antigen, ~80aa
MBS600706-01mg 0.1mg
EUR 700

Hepatitis B Core Antigen, ~80aa
MBS600706-5x01mg 5x0.1mg
EUR 3010

HLA Class 1 Antigen A1,A36
MBS600331-01mL 0.1mL
EUR 1415

HLA Class 1 Antigen A1,A36
MBS600331-5x01mL 5x0.1mL
EUR 6225
Small interfering RNA (siRNA) knockdown of PI4KB, a human homolog of Pik1, inhibited the survival of Mtb in macrophages, figuring out PI4KB as an unexploited molecular goal for efforts to develop HDT medicine for remedy of TB.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here